RxDoctor Payments Data

Nicole Chieka

Gerontology · Colorado Springs, CONPI 1588192363

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (55.4%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Medtronic at 55.0% of the total. Reporting peaked in 2023 at $3,333 and has fallen 93.7% since, to $211 in 2025. Among gerontology clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,986in general payments, 2019–2025

Across 63 payments — averaging $95.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Medical Device Business Services, Inc.$1K
  • Biosense Webster, Inc.$289
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$183
  • Boston Scientific$161
  • Abbott$149
  • plus $785 from 11 others

What the payments were for

  • Consulting fees$4908%
  • Travel & lodging$3,31355%
  • Food & beverage$2,16436%
  • Education$180%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,986 in reported general payments places this provider in the 95th percentile of 85 gerontology providers in Colorado.

See all gerontology providers in Colorado

Medicare billing

Part B allowed, 2024
$51,873
Medicare patients
476
Services billed
594

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban90$99,078
XareltoRivaroxaban32$37,739
Flecainide Acetate43$1,601
Metoprolol Succinate86$1,285
Amiodarone Hcl64$1,281
Dofetilide16$1,045
SotalolSotalol Hcl40$849
Diltiazem 24hr Er (Cd)Diltiazem Hcl16$427
Metoprolol Tartrate31$170
Furosemide11$20

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$64$99,07890 claims
Johnson & JohnsonXarelto$30$37,73932 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 85 gerontology providers in Colorado.

Other gerontology in Colorado Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →